Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Pittsburgh, PA
SEC filing record 1 source field available
Fiscal year end
31 December
NeuBase Therapeutics, Inc. has filed 670 SEC EDGAR filings since 16 May 2002

SEC filing history

Showing 1-25 of 49 matching filings.

Per page
25
Current page
1
10-Q File 001-35963

QUARTERLY REPORT

Filing date
14 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
15 May 2019
Reporting date
31 Mar 2019
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
14 Feb 2019
Reporting date
31 Dec 2018
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
14 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
15 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
14 Feb 2018
Reporting date
31 Dec 2017
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
08 Aug 2017
Reporting date
30 Jun 2017
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
11 May 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
14 Feb 2017
Reporting date
31 Dec 2016
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
09 Aug 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
10-Q File 001-35963

QUARTERLY REPORT

Filing date
10 May 2016
Reporting date
31 Mar 2016
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .